Editorial: Cardiovascular risk in PCOS

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 8, 2004, Pages 3694-3695

  Guzick, David S ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERY INTIMA PROLIFERATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; EDITORIAL; ENDOMETRIUM CANCER; FEMALE INFERTILITY; GLUCOSE INTOLERANCE; GROUPS BY AGE; HEART LEFT VENTRICLE HYPERTROPHY; HIRSUTISM; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MENSTRUAL IRREGULARITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARIECTOMY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SMOKING; FEMALE; NOTE; RISK ASSESSMENT;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; RISK ASSESSMENT;

EID: 4344639792     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1136     Document Type: Editorial

References (14)

1. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
2. Legro RS 2001 Diabetes prevalence and risk factors in polycystic ovarian syndrome. Obstet Gynecol Clin North Am 28:99-109
3. Reaven GM 1993 Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44:121-131
4. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
5. Talbott EO, Guzick DS, Clerici A, Berga S, Detre K, Weimer K, Kuller L 1995 Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821-826
6. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N 2001 Low-grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 86:2453-2455
7. Schachter M, Raziel A, Friedler S, Strassburger D, Bern O, Ron-El R 2003 Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 18:721-727
8. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu K, Zborowski J, Remsberg K, Kuller L 2000 Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20:2414-2421
9. Christian RC, Dumesic DA, Behrenbeck T, Oberg A, Sheedy PF, Fitzpatrick L 2003 Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2562-2568
10. Orio F, Palomba S, Spinellli L, Cascella T, Tauchmanova L, Zullo F, Lombardi G, Colao A 2004 The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab 89:3696-3701
11. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V 1999 Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement from the American Heart Association and the American College of Cardiology. Circulation 1000:1481-1492
12. Pierpoint T, McKeigue P, Isaacs A, Jacobs HS 1998 Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51:581-586
13. Wild S, Pierpoint T, McKeigue, Jacobs H 2000 Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 52:595-600
14. Solomon C, Hu F, Dunaif A, Rich-Edwards J, Stampfer M, Willett W, Speizer F, Manson J 2002 Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 87:2013-2017